Cargando…
Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population
BACKGROUND: YKL-40 and C-reactive protein (CRP) are biomarkers that may reflect cancer-related subclinical inflammation. We assessed elevated YKL-40 and CRP levels as combined risk predictors for cancer. METHODS: We measured plasma YKL-40 and CRP at baseline in 8706 individuals from the Danish gener...
Autores principales: | Allin, K H, Bojesen, S E, Johansen, J S, Nordestgaard, B G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251851/ https://www.ncbi.nlm.nih.gov/pubmed/22095223 http://dx.doi.org/10.1038/bjc.2011.501 |
Ejemplares similares
-
Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers
por: Shao, R, et al.
Publicado: (2011) -
Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease
por: Blanco-Palmero, Víctor Antonio, et al.
Publicado: (2021) -
Combined plasma C‐reactive protein, interleukin 6 and YKL‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer
por: Videmark, Alex N., et al.
Publicado: (2022) -
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
por: Szkandera, J, et al.
Publicado: (2014) -
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study
por: Allin, Kristine H, et al.
Publicado: (2011)